Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 179 (RNA5SP179) is a human pseudogene annotated as a non-functional copy of the 5S ribosomal RNA gene, meaning it resembles a functional rRNA gene but does not encode an active ribosomal RNA or protein product[5][6]. Pseudogenes such as RNA5SP179 arise by gene duplication or retrotransposition events, accumulating mutations that prevent them from producing functional transcripts or proteins[4][5]. 5S rRNA itself is a key component of the large ribosomal subunit, but RNA5SP179, like most pseudogenes, does not produce a functional RNA and is not a receptor, enzyme, or therapeutic target[1][2][5][6]. Some research suggests that the expression profiles of pseudogenes may serve as biomarkers in cancer biology, but there is no specific evidence for RNA5SP179 having such a role[8]. There are no known drugs, safety concerns, or established biological functions associated with this pseudogene. Its primary relevance is in genome annotation and, more generally, in studies of pseudogene function and possible roles in gene regulation or disease through non-coding RNA effects[8].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 179 (RNA5SP179).